prescription drugs

J & J faces thousands of Risperdal lawsuits

More than 5,000 lawsuits have been filed against Johnson & Johnson for failure to warn doctors and consumers that Risperdal can cause boys to grow large breasts, a condition known as gynecomastia. Risperdal Litigation At least 1,500 Risperdal cases have been consolidated in Pennsylvania on behalf of individuals who allege the drug caused excessive male breast...

read more

Is Your Doctor Giving You Fake Drugs?

It seems that even doctors can fall prey to the same counterfeit drug scams that have plagued consumers. We received an email today, which announced the FDA has launched a new website, warning health care professionals about a growing trend: Fake drug distributors. “There is a growing network of rogue wholesale drug distributors selling...

read more

The Trouble with Low T Treatments

Have you noticed the ever-increasing collection of commercials targeting men with low testosterone, or “Low T?” Much like the advertising for Viagra and other ED medications, these ubiquitous sales pitches prey on the insecurities of mature men with promises of increased vitality, improved muscle mass, alleviating depression, and improved sexual performance. But for some...

read more

Glaxo to End Some Payments to Doctors

In a surprising announcement, pharmaceutical giant GlaxoSmithKline revealed they will soon put an end to a common industry practice of paying doctors and other health professionals to promote their drugs. The company said it will stop paying doctors to endorse its products at speaking engagements and no longer base the pay of sales representatives...

read more

China Charges Drug Company with Bribery

Pharmaceutical giant GlaxoSmithKline has been accused of bribing government officials and doctors to boost its drug sales in China. According to Chinese officials, the British drugmaker was involved in a conspiracy involving hundreds of millions of dollars that has spanned several years. Chinese authorities claim that senior Glaxo executives used travel agencies to launder...

read more

First Non-hormonal Drug Approved by FDA for Hot Flashes

If you've been suffering from hot flashes and night sweats, but were reluctant to take medications with hormones, you now have an alternative. The FDA announced that it has approved Brisdelle, the first non-hormonal drug to treat moderate to severe hot flashes. That’s great news, right? Well, sort of. It turns out the drug...

read more

Illegal Online Pharmacies Shut Down

Faced with mounting medical bills, American consumers have flocked to the internet in search of “Canadian Pharmacies” selling bargain-priced prescription drugs. What they may not know is that the drugs may actually come from overseas and many of the websites are illegal, selling dangerous unapproved medications. The FDA released a statement yesterday stating that...

read more

New Safety Review of Diabetes Drugs

  Possible link to cancer The American Diabetes Association (ADA) has called for an independent safety review of drugs used to control blood sugar for patients with Type 2 Diabetes.  The ADA issued a statement this week asking pharmaceutical companies to “make patient-level data on their products available for an independent review that could...

read more

Comeback for Avandia?

Once the world’s best-selling treatment for type 2 diabetes, GlaxoSmithKline’s Avandia is currently banned in Europe and severely restricted in the U.S – due to an increased risk of heart attack and stroke. But new recommendations from federal health advisors may change things. The New York Times reports, “A panel of experts voted Thursday...

read more

FDA launches online pharmacy awareness campaign, helps ID licensed websites

For millions of Americans, a large percentage of their monthly budgets must go toward prescription medications. Millions of dollars are spent on prescription drugs each year in our country. Ninety percent of senior citizens and 57 percent of non-senior citizens rely on at least one prescription drug on a daily basis. Combine these numbers...

read more